HDAC inhibitor SNDX-275 enhances efficacy of trastuzumab in erbB2-overexpressing breast cancer cells and exhibits potential to overcome trastuzumab resistance.
published in: Cancer Letters
date of publication: 2011-04-16
language: English
main subject: overexpression, entinostat, trastuzumab
Cites articles
There is nothing here
Article - wd:Q45259942